APhexmutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells

Clinical variability of familial tumoral calcinosis caused by novelGALNT3mutations

(2010) Shoji Ichikawa et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Treatment of X-Linked Hypophosphatemia with Calcitriol and Phosphate Increases Circulating Fibroblast Growth Factor 23 Concentrations

(2010) Erik A. Imel et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Regulation of Parathyroid Hormone Secretion and Synthesis

(2010) R. Kumar et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Ablation of theGalnt3Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite IncreasedFgf23Expression

(2009) Shoji Ichikawa et al.   ENDOCRINOLOGY

Effects of hPTH(1-34) Infusion on Circulating Serum Phosphate, 1,25-Dihydroxyvitamin D, and FGF23 Levels in Healthy Men

(2009) Sherri-Ann M Burnett-Bowie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation

(2009) R. Goetz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients

(2008) Itsuro Endo et al.   BONE

Calcimimetics as an Adjuvant Treatment for Familial Hypophosphatemic Rickets

(2008) U. S. Alon et al.   Clinical Journal of the American Society of Nephrology

Anti-FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23

(2008) Yuji Yamazaki et al.   JOURNAL OF BONE AND MINERAL RESEARCH